Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system

By Ruitenberg M.J.   Eggers R.   Boer G.J.   Verhaagen J.  

Methods, Vol. 28, Iss. 2, 2002-10 ,pp. : 182-194

Academic Press

Access to resources Recommend Favorite

Gene delivery to the eye using adeno-associated viral vectors

By Martin K.R.G.   Klein R.L.   Quigley H.A.  

Methods, Vol. 28, Iss. 2, 2002-10 ,pp. : 267-275

Academic Press

Access to resources Recommend Favorite

Gene therapy for Parkinson’s disease using recombinant adeno-associated viral vectors

By Muramatsu Shin-ichi   Tsukada Hideo   Nakano Imaharu   Ozawa Keiya  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 5, 2005-05 ,pp. : 663-671

Informa Healthcare

Access to resources Recommend Favorite

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

By Zolotukhin S.   Potter M.   Zolotukhin I.   Sakai Y.   Loiler S.   Fraites T.J.   Chiodo V.A.   Phillipsberg T.   Muzyczka N.   Hauswirth W.W.   Flotte T.R.   Byrne B.J.   Snyder R.O.  

Methods, Vol. 28, Iss. 2, 2002-10 ,pp. : 158-167

Academic Press

Access to resources Recommend Favorite

Recombinant adeno-associated virus vectors for gene therapy

By Conlon Thomas J   Flotte Terence R  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 7, 2004-07 ,pp. : 1093-1101

Informa Healthcare

Access to resources Recommend Favorite